Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
European Radiology|November 13, 2022
Deep learning algorithm performs similarly to radiologists in the assessment of prostate volume on MRIErik Thimansson, J Bengtsson, E Baubeta, et al.
The Prostate|March 26, 2004
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell linesN Dizeyi, A Bjartell, E Nilsson, et al.
Urology|November 1, 1993
Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epitheliumA Bjartell, T Björk, M T Matikainen, et al.
British Journal of Cancer|August 8, 2013
The tumour suppressor miR-34c targets MET in prostate cancer cellsZ Hagman, B S Haflidadottir, M Ansari, et al.
The American Journal of Pathology|December 7, 2000
Expression and characterization of trypsinogen produced in the human male genital tractA Paju, A Bjartell, W M Zhang, et al.
Peptides|September 1, 1991
Human pheochromocytoma cells studied in culture contain large amounts of DSIP-like materialO Nilsson, B Wängberg, A Wigander, et al.
Acta Endocrinologica|December 1, 1988
Carcinoma of the prostate with Cushing's syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissueA Fjellestad-Paulsen, P A Abrahamsson, A Bjartell, et al.
Oncogene|May 29, 1999
FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent diseaseT J Dorkin, M C Robinson, C Marsh, et al.
International Journal of Oncology|December 6, 2005
Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancerK Hotakainen, A Bjartell, A Sankila, et al.
British Journal of Cancer|April 11, 2013
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patientsZ Hagman, B S Haflidadóttir, J A Ceder, et al.
Pageof 7